Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Building Better Medicines: Exploring AI-Driven Compound Optimization

An expert interview on research into AI-driven drug optimization.

Article

AI Readiness in the Industrial Sector - Do's and Don'ts

To our first edition of "The AI Interview" series on AI Readiness in the Industrial Sector.

Article

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Article

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.